Completed NA INTERVENTIONAL 2-arm NCT05588479

Pomegranate Extract and Inflammageing

Effects of Pomegranate Extract on Inflammatory Markers, Physical and Cognitive Function and Cardiometabolic Risk Factors in Older Adults: a Randomised Parallel Trial

Sponsor: Manchester Metropolitan University

Conditions Aging

Interventions Control Pomegranate extract

Updated 6 times since 2022 Last updated: Jan 17, 2025 Started: Dec 10, 2022 Primary completion: Jun 30, 2024 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Aging, this trial is completed. The trial is conducted by Manchester Metropolitan University and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2024 — Jul 2024 [monthly]

Recruiting NA
Apr 2023 — Mar 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2022 — Apr 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Manchester Metropolitan University

Data source: Manchester Metropolitan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manchester, United Kingdom